1130532
Last Update Posted: 2013-01-04
Recruiting has ended
Males accepted | 18 Years + |
623 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study in Erectile Dysfunction
The purpose of this trial is to evaluate if treatment with tadalafil once daily will allow men to return to normal erectile function in those who did not have normal erectile function following as-needed (PRN) Phosphodiesterase Type 5 (PDE5) Inhibitor treatment.
Eligibility
Relevant conditions:
Erectile Dysfunction
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov